Neuroanaesthesia & neurocritical care

Decisions to withdraw or withhold life-sustaining therapies in patients with and without acute brain injury: a secondary analysis of two prospective cohort studies

Lancet Respir MedPublished Secondary analysis of two prospective cohort studies

Authors' conclusion

Our findings suggest that WLST decisions are significantly more common in patients with ABI versus patients without ABI and occur earlier in this group.

Study context

Population
Invasively or non-invasively ventilated intensive care unit (ICU) patients, 40 countries, 2004–201616,791 in WLST analysis
Participants
21,970 participants
Comparison
Patients with vs without acute brain injury
  • ABIn = 2,191
  • Non-ABIn = 14,600reference
Primary endpoint
Incidence and timing of WLST
Methodological detailsinternational, multilevel logistic regression
  • International
  • Multilevel logistic regression

Primary result

As reported in the abstract

WLST incidence
Each group vs Non-ABIRisk difference (95% CI)
ABI
5.5%(3.8–7.1)
Each group vs Non-ABIOdds ratio (95% CI)
ABI
2.42(1.89–3.12)

Further findings

Median, days

OutcomeABINon-ABIAbsolute difference (days) (95% CI)
Time to WLST after ICU admission4 (IQR 2–9)6 (IQR 2–13)2 (1–3)
OutcomeABINon-ABI
Between-ICU variability in WLST decisionsVariability high
Median OR3.04 (95% CI 2.54-3.67)2.59 (2.38-2.78)

Subgroups (ABI subgroups, world regions, cohort years)

Findings similar across ABI subgroups, world regions, and cohort years

Original publication

Decisions to withdraw or withhold life-sustaining therapies in patients with and without acute brain injury: a secondary analysis of two prospective cohort studies. Lancet Respir Med. Published 17 March 2025. doi:10.1016/s2213-2600(24)00404-1

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.